Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1972;45:543-551

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TOMPKINS, D. G.
Right arrow Articles by LIEBMAN, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TOMPKINS, D. G.
Right arrow Articles by LIEBMAN, J.

(Circulation. 1972;45:543.)
© 1972 American Heart Association, Inc.


Long-Term Prognosis of Rheumatic Fever Patients Receiving Regular Intramuscular Benzathine Penicillin

DOROTHY G. TOMPKINS M.D.1; BERNARD BOXERBAUM M.D.1; JEROME LIEBMAN M.D.1

1 From the Rainbow Rheumatic Fever Clinic, Babies and Childrens Hospital, and the Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, Ohio.

The prognosis for 115 rheumatic fever patients subsequently receiving regular intramuscular penicillin prophylaxis for at least 5 years was studied. Average follow-up was 9.3 years, and 57 patients were followed for 10 years or longer. Of the 79 patients with acute mitral regurgitation, 70% lost their murmur from 4 days to 8.5 years after it was first heard. This is in contrast to those with acute aortic regurgitation which persisted in 73%. No patient developed mitral or aortic stenosis: this suggests that regular prophylaxis may prevent the development of stenosis. Congestive failure, cardiomegaly, and arrhythmia correlated closely with persistence of murmurs, but increased P-R interval, acute QRS or T-voltage variation or both, and ST-T abnormalities did not.


Key Words: Rheumatic valvulitis • Rheumatic prophylaxis • Rheumatic heart disease

Submitted on November 6, 1970
Accepted on October 20, 1971




This article has been cited by other articles:


Home page
HeartHome page
M McDonald, A Brown, S Noonan, and J R Carapetis
Preventing recurrent rheumatic fever: the role of register based programmes
Heart, September 1, 2005; 91(9): 1131 - 1133.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
Z M A Meira, E M A Goulart, E A Colosimo, and C C C Mota
Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents
Heart, August 1, 2005; 91(8): 1019 - 1022.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Narula, Y. Chandrasekhar, and S. Rahimtoola
Diagnosis of Active Rheumatic Carditis : The Echoes of Change
Circulation, October 5, 1999; 100(14): 1576 - 1581.
[Full Text] [PDF]


Home page
CirculationHome page
R. S. Vasan, S. Shrivastava, M. Vijayakumar, R. Narang, B. C. Lister, and J. Narula
Echocardiographic Evaluation of Patients With Acute Rheumatic Fever and Rheumatic Carditis
Circulation, July 1, 1996; 94(1): 73 - 82.
[Abstract] [Full Text]